PharmaVOICE - 
September 2008
Purchase Issue

In Every Issue
Last Word
Jason Cohen joined GE Healthcare Financial Services in 2006 and [...]
By
Talent Pool
Pharma POOL Brian AYRES Jason CARLIN Dr. Maria DEUTSCH Susan [...]
By
On the Calendar
4th Integrating Electronic Health Records and eClinical Technologies Conference Baltimore [...]
By
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: [...]
By
What’s New
WHAT’S NEW NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES [...]
By
PharmaTrax
“The neurotechnology industry made substan tial gains in 2007, which [...]
By
PharmaOutlet
The words “corporate social responsibility” are flooding the headlines. While [...]
By

William Clapper

UpFront
MARKET BUSTERS Global Drug Market to Exceed Trillion According [...]
By
Letter from the Editor
As the summer comes to an end and the hint [...]
By

Taren Grom, Editor

On The Cover

When Smaller is Better
BY ROBIN ROBINSON As the industry turns its attention toward specialty products in the hopes of filling drying pipelines, smaller pharma and biotech companies may find themselves in the driver’s seat. Despite all of the hurdles facing the specialty industry — the FDA’s slow down in new drug approvals and tightened safety requirements — brands [...]
By

Robin Robinson

Features

DIA 2008 — Annual Conference
DIA 2008 DIA ADDRESSES SAFETY TOPICS The 44th Annual Meeting of the Drug Information Association Industry Thought Leaders Raise their VOICE at DIA David Williams of Clinsys discusses what he believes the industry’s biggest challenges are. Imperial’s Bob McGrath identifies risk mitigation as one of the biggest challenges facing the industry today. Sheila Rocchio of [...]
By
The Growing Influence of Global Payers
Managed MARKETS The balance of power is shifting. Global payers are now demanding more data about the cost effectiveness of prescription drugs. And experts say they will continue to do so.Driving the increas ing use of health technology assessments (HTA) by governments to make reimbursement, and sometimes even pricing, decisions is the rising cost of [...]
By

Denise Myshko

Leveraging Postapproval Research
Only a few short years ago, both product management and product marketing were considered relatively straightforward and uncomplicated activities. Sales representatives were more likely to have greater access to physicians and healthcare providers, and fewer restrictions were placed on marketing activities. “Once a product received regulatory approval, subsequent research activities were generally considered complete, except [...]
By

Craig Eslinger

Michael Pucci — The Man, The Mission, The Message
BY TAREN GROM He started as one man with a mission five years ago. Today Michael Pucci is inspiring legions as one of the industry’s staunchest advocates as he strives to improve the image of pharma with a message based on science and solid data. MAN THE MISSION THE MESSAGE THE PV0908LayoutFINAL 8/20/08 11:40 AM [...]
By

Taren Grom, Editor

The Green Movement: Rethinking Chemistry
BY DENISE MYSHKO Major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. The GREEN MOVEMENT Rethinking Chemistry GREEN IS THE NEW BLACK. The push to make prescription drugs more efficient, cleaner, and safer is gaining momentum amid growing awareness that the manufacturing process is where the industry [...]
By

Denise Myshko

A New Era of Drug Safety
BY DENISE MYSHKO NEW REGULATIONS IN THE UNITED STATES AND EUROPE HAVE TRIGGERED A NEED FOR BETTER TOOLS FOR THE COLLECTING, REPORTING,AND ANALYSIS OF PATIENT SAFETY DATA. As regulators around the globe demand more data on each drug’s profile, the need for technologies to support drug safety has become more pressing. This will require compa [...]
By

Denise Myshko

FEEDBACK